Impact of PCSK9 inhibitors Alirocumab and Evolocumab on total & LDL cholesterol in clinical practice. (September 2017)

Record Type:: Journal Article
Title:: Impact of PCSK9 inhibitors Alirocumab and Evolocumab on total & LDL cholesterol in clinical practice. (September 2017)
Main Title:: Impact of PCSK9 inhibitors Alirocumab and Evolocumab on total & LDL cholesterol in clinical practice
Authors:: Capps, N.
Abstract:
Is Part Of:: Atherosclerosis. Volume 28(2017)
Journal:: Atherosclerosis
Issue:: Volume 28(2017)
Issue Display:: Volume 28, Issue 2017 (2017)
Year:: 2017
Volume:: 28
Issue:: 2017
Issue Sort Value:: 2017-0028-2017-0000
Page Start:: e13
Page End:
Publication Date:: 2017-09
Subjects:: Atherosclerosis -- Periodicals
Cardiovascular system -- Diseases -- Periodicals
Periodicals
616.136
Journal URLs:: http://www.sciencedirect.com/science/journal/15675688 ↗
http://www.elsevier.com/journals ↗
DOI:: 10.1016/j.atherosclerosissup.2017.08.023 ↗
Languages:: English
ISSNs:: 1567-5688
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 1765.875000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 9464.xml